{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:00:03Z","timestamp":1785160803008,"version":"3.55.0"},"reference-count":39,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Lundbeck Foundation","award":["R155-2014-171"],"award-info":[{"award-number":["R155-2014-171"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cephalalgia"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human models of migraine have been used for the past 30 years to test putative \u2018trigger\u2019 molecules and ascertain whether they induce migraine attacks in humans. However, nocebo effects using this model have never been systematically explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the nocebo response rate in randomised clinical trials conducted at the Danish Headache Center, and in which human models of migraine were used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this systematic review and meta-analysis, we searched PubMed for studies of human models of migraine with a randomised, double-blind, placebo-controlled, two-way crossover design that included data on the incidence of migraine attacks or headache after infusion of placebo. A total of 943 articles were screened by title and abstract. Of these, 27 studies met the inclusion criteria (published between 1994 and 2020) and were included in the qualitative and quantitative analysis. We performed a random effects meta-analysis for the incidence of migraine attacks or delayed headache after placebo infusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-seven studies were eligible for inclusion: 12 studies reported data for adults with migraine (n\u2009=\u2009182), whereas 16 studies reported data on healthy volunteers (n\u2009=\u2009210). For adults with migraine, the incidence of migraine attacks after placebo was 8.1% (95% CI\u2009=\u20092.5\u201315.5%, I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200950.8%). The incidence of delayed headache was 25.9% (95% CI\u2009=\u200918.5\u201334.1%, I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200918.9%). For healthy volunteers, the incidence of migraine attacks after placebo was 0.5% (95% CI\u2009=\u20090.0\u20133.6%, I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.0%) while the incidence of delayed headache was 10.5% (95% CI\u2009=\u20094.8\u201317.6%, I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200945.2%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The nocebo response in randomised, placebo-controlled two-way crossover trials with intravenous infusions of placebo in migraine is negligible. Future studies using human models of migraine can be conducted by assuming a nocebo response rate of 15.5%.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/0333102420970489","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T07:03:48Z","timestamp":1606374228000},"page":"99-111","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":22,"title":["Nocebo response in human models of migraine: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled, two-way crossover trials in migraine without aura and healthy volunteers"],"prefix":"10.1177","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7954-8519","authenticated-orcid":false,"given":"Hashmat","family":"Ghanizada","sequence":"first","affiliation":[{"name":"Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afrim","family":"Iljazi","sequence":"additional","affiliation":[{"name":"Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Ashina","sequence":"additional","affiliation":[{"name":"Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thien Phu","family":"Do","sequence":"additional","affiliation":[{"name":"Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1118-9665","authenticated-orcid":false,"given":"Mohammad Al-Mahdi","family":"Al-Karagholi","sequence":"additional","affiliation":[{"name":"Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal Mohammad","family":"Amin","sequence":"additional","affiliation":[{"name":"Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Messoud","family":"Ashina","sequence":"additional","affiliation":[{"name":"Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","unstructured":"Ashina M. Migraine. N Engl J Med 2020; 383: 1866--1876.","DOI":"10.1056\/NEJMra1915327"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102412475234"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","unstructured":"Ashina H Schytz HW and Ashina M. CGRP in human models of primary headaches. Cephalalgia 2018; 38: 353--360.","DOI":"10.1177\/0333102416684344"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","unstructured":"Ashina M Hansen JM Do TP et al. Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol 2019; 18: 795--804.","DOI":"10.1016\/S1474-4422(19)30185-1"},{"key":"e_1_3_2_6_2","first-page":"9","article-title":"The International Classification of Headache Disorders, 2nd edition","volume":"24","author":"Headache Classification Committee of the International Headache Society.","year":"2004","unstructured":"Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004; 24: 9\u2013160.","journal-title":"Cephalalgia"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"key":"e_1_3_2_8_2","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","volume":"8","author":"Headache Classification Committee of the International Headache Society","year":"1988","unstructured":"Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8: 1\u201396.","journal-title":"Cephalalgia"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","unstructured":"Higgins JPT Savovi\u0107 J Page MJ et al. Assessing risk of bias in a randomized trial. In: Higgins JPT Thomas J Chandler J et al. (eds.) Cochrane Handbook for Systematic Reviews of Interventions version 6.1. Cochrane 2020. www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch8"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.1994.tb00053.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2002.00310.x"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2007.01497.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2009.01929.x"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn307"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102412451360"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz199"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102419864507"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2009.01923.x"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.9.1830"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","unstructured":"Birk S Petersen KA Kruuse C et\u00a0al. The effect of circulating adenosine on cerebral haemodynamics and headache generation in healthy subjects. Cephalalgia 2005; 25: 369--77.","DOI":"10.1111\/j.1468-2982.2005.00867.x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2006.01149.x"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2006.01257.x"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01715.x"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01748.x"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.03.018"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102411423314"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410373156"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2014.05.019"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420937655"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2000.00116.x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01739.x"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","unstructured":"Ghanizada H Al-Karagholi MA Arngrim N et al. Adrenomedullin induces migraine-like attacks in patients with migraine without aura. In: Proceedings of EHF Congress Berlin Germany 1 July 2020. European Headache Federation.","DOI":"10.1177\/0333102419864507"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420940681"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01695.x"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X19874295"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-019-02104-x"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","unstructured":"Kenward MG and Jones B. Design and analysis of cross-over Trials. In: Rao CR Miller JP and Rao DC (eds) Epidemiology and Medical Statistics Handbook of statistics vol 27. Amsterdam Oxford: North-Holland (an imprint of Elsevier) 2008 pp. 464--490.","DOI":"10.1016\/S0169-7161(07)27015-4"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3976"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1159\/000490354"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1037\/1522-3736.6.1.61a"}],"container-title":["Cephalalgia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0333102420970489","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0333102420970489","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0333102420970489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:48:57Z","timestamp":1777387737000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0333102420970489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1177\/0333102420970489"],"URL":"https:\/\/doi.org\/10.1177\/0333102420970489","relation":{},"ISSN":["0333-1024","1468-2982"],"issn-type":[{"value":"0333-1024","type":"print"},{"value":"1468-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,26]]}}}